Cargando…

PCR-based Diagnosis of Mucormycosis Targeting Mucorales-specific Genes

BACKGROUND: Mucormycosis is a life-threatening infection caused by fungi in the order Mucorales. Among them, Rhizopus spp. are responsible for 50-70% of all cases of mucormycosis, followed by Mucor spp. and Lichtheimia spp. Standard treatment of mucormycosis involves surgical removal of infected tis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baldin, Clara, Soliman, Sameh, Jeon, Heewon, Gebremariam, Teclegiorgis, Alkhazraji, Sondus, Bruno, Vincent, Edwards, John, Ibrahim, Ashraf
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631376/ http://dx.doi.org/10.1093/ofid/ofx163.1609

Ejemplares similares

969. GRP78 and Integrin β1/α3 Play Disparate Roles in Epithelium Invasion During Mucormycosis
por: Alqarihi, Abdullah, et al.
Publicado: (2018)

2393. Evaluation of Antifungal Treatment in a Neutropenic Mouse Model of Scedosporiosis
por: Alkhazraji, Sondus, et al.
Publicado: (2018)

119. A Humanized Antibody Targeting the CotH Invasins is Protective Against Murine Mucormycosis
por: Gu, Yiyou, et al.
Publicado: (2021)

LB1580. Efficacy Assessment of MAT2203 Encochleated Oral Formulation of Amphotericin B, in the Neutropenic Mouse Model of Pulmonary Mucormycosis
por: Gebremariam, Teclegiorgis, et al.
Publicado: (2022)

GRP78 and Integrins Play Different Roles in Host Cell Invasion during Mucormycosis
por: Alqarihi, Abdullah, et al.
Publicado: (2020)

Anti-CotH3 antibodies protect mice from mucormycosis by prevention of invasion and augmenting opsonophagocytosis
por: Gebremariam, Teclegiorgis, et al.
Publicado: (2019)

1705. Filamentous Hemagglutinin Polyclonal Antibodies Protect against Multidrug resistant Gram-negative bacteria
por: Youssef, Eman, et al.
Publicado: (2022)

Inhibition of EGFR Signaling Protects from Mucormycosis
por: Watkins, Tonya N., et al.
Publicado: (2018)

Evaluation of Sex Differences in Murine Diabetic Ketoacidosis and Neutropenic Models of Invasive Mucormycosis
por: Gebremariam, Teclegiorgis, et al.
Publicado: (2021)

Mucoricin is a Ricin-Like Toxin that is Critical for the Pathogenesis of Mucormycosis
por: Soliman, Sameh S. M., et al.
Publicado: (2021)

Fosmanogepix (APX001) Is Effective in the Treatment of Pulmonary Murine Mucormycosis Due to Rhizopus arrhizus
por: Gebremariam, Teclegiorgis, et al.
Publicado: (2020)

APX001 Is Effective in the Treatment of Murine Invasive Pulmonary Aspergillosis
por: Gebremariam, Teclegiorgis, et al.
Publicado: (2019)

APX001A Protects Immunosuppressed Mice from Rhizopus delemar Infection
por: Gebremariam, Teclegiorgis, et al.
Publicado: (2017)

Optimization of the CRISPR/Cas9 System to Manipulate Gene Function in Rhizopus delemar
por: Baldin, Clara, et al.
Publicado: (2017)

The Combination Treatment of Fosmanogepix and Liposomal Amphotericin B Is Superior to Monotherapy in Treating Experimental Invasive Mold Infections
por: Gebremariam, Teclegiorgis, et al.
Publicado: (2022)

2038. Invasive Mucormycosis Management: Mucorales PCR Provides Important, Novel Diagnostic Information
por: Wilgers, Kyle, et al.
Publicado: (2018)

745. Combination Treatment of Liposomal Amphotericin B and Isavuconazole is Synergistic in Treating Experimental Mucormycosis
por: Gebremariam, Teclegiorgis, et al.
Publicado: (2020)

Galactomannan Is a Biomarker of Fosmanogepix (APX001) Efficacy in Treating Experimental Invasive Pulmonary Aspergillosis
por: Gebremariam, Teclegiorgis, et al.
Publicado: (2019)

Special Issue: Mucorales and Mucormycosis
por: Dannaoui, Eric, et al.
Publicado: (2019)

678. Galactomannan Is a Biomarker of APX001 (Fosmanogepix) Efficacy in Treating Experimental Invasive Pulmonary Aspergillosis
por: Gebremariam, Teklegiorgis, et al.
Publicado: (2019)

726. APX001 (Fosmanogepix) Is Effective in an Immunosuppressed Mouse Model of Rhizopus oryzae Infection
por: Gebremariam, Teklegiorgis, et al.
Publicado: (2019)

Fosmanogepix (APX001) Is Effective in the Treatment of Immunocompromised Mice Infected with Invasive Pulmonary Scedosporiosis or Disseminated Fusariosis
por: Alkhazraji, Sondus, et al.
Publicado: (2020)

255. Breakthrough Mucormycosis (BT-MCR) on Antifungals Having Mucorales Activity Portrays Worse Prognosis compared with BT-MCR on Mold-Active Antifungals with no Mucorales Activity
por: Axell-House, Dierdre B, et al.
Publicado: (2019)

Monoclonal IgM Antibodies Targeting Candida albicans Hyr1 Provide Cross-Kingdom Protection Against Gram-Negative Bacteria
por: Youssef, Eman G., et al.
Publicado: (2020)

Mucorales and Mucormycosis: Recent Insights and Future Prospects
por: Tahiri, Ghizlane, et al.
Publicado: (2023)

Combination treatment of liposomal amphotericin B and isavuconazole is synergistic in treating experimental mucormycosis
por: Gebremariam, Teclegiorgis, et al.
Publicado: (2021)

Genetic Manipulation in Mucorales and New Developments to Study Mucormycosis
por: Lax, Carlos, et al.
Publicado: (2022)

2102. Common co-occurence in the respiratory tract of Mucorales with Gram-negative rods in patients with hematologic malignancy and sinopulmonary mucormycosis
por: Egge, Stephanie L, et al.
Publicado: (2022)

812. Bacterial endosymbionts are frequently found among Mucorales clinical isolates. Should we screen for their presence in patients with Mucormycosis?
por: Leon, Dora Edith Corzo, et al.
Publicado: (2023)

1725. Shear Forces Induce a Transient, Calcineurin-Dependent Hyper-Virulent Phenotype in Mucorales via Soluble Factors
por: Wurster, Sebastian, et al.
Publicado: (2019)

97. A Cross-kingdom Vaccine Protects against Multiple Healthcare-associated Infections
por: Singh, Shakti, et al.
Publicado: (2022)

Molecular mechanisms of mucormycosis—The bitter and the sweet
por: Baldin, Clara, et al.
Publicado: (2017)

An integrated genomic and transcriptomic survey of mucormycosis-causing fungi
por: Chibucos, Marcus C., et al.
Publicado: (2016)

Mucorales PCR in blood as an early marker of invasive gastrointestinal mucormycosis might decrease the delay in treatment: A case report
por: Aerts, Robina, et al.
Publicado: (2022)

Is It Time to Include CT “Reverse Halo Sign” and qPCR Targeting Mucorales in Serum to EORTC-MSG Criteria for the Diagnosis of Pulmonary Mucormycosis in Leukemia Patients?
por: Caillot, Denis, et al.
Publicado: (2016)

Serial Detection of Circulating Mucorales DNA in Invasive Mucormycosis: A Retrospective Multicenter Evaluation
por: Mercier, Toine, et al.
Publicado: (2019)

Evaluation of environmental Mucorales contamination in and around the residence of COVID-19-associated mucormycosis patients
por: Ghosh, Anup K., et al.
Publicado: (2022)

Blood Mucorales PCR to track down Aspergillus and Mucorales co-infections in at-risk hematology patients: A case-control study
por: Aerts, Robina, et al.
Publicado: (2022)

Genetic diversity of clinical and environmental Mucorales isolates obtained from an investigation of mucormycosis cases among solid organ transplant recipients
por: Nguyen, M. Hong, et al.
Publicado: (2020)

Breakthrough Mucormycosis Developing on Mucorales-Active Antifungals Portrays a Poor Prognosis in Patients with Hematologic Cancer
por: Axell-House, Dierdre B., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6h6et16rq1usipd6nedna9jlp8